首席执行官
Mahesh V. Patel, Ph.D. is the co-founder, Chairman, President, and Chief Executive Officer of Lipocine Inc. (LPCN), a biopharmaceutical company focused on drug delivery technologies.[[1]](https://biography.omicsonline.org/united-states-of-america/lipocine-inc/mahesh-v-patel-phd-895860)[[2]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lpcn/lipocine/management)[[3]](https://www.lipocine.com/lipocine-management/) He has held these leadership roles since co-founding the company in 1997, with a tenure exceeding 29 years as of recent records, during which he also serves as Interim Principal Financial Officer.[[1]](https://biography.omicsonline.org/united-states-of-america/lipocine-inc/mahesh-v-patel-phd-895860)[[2]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lpcn/lipocine/management)
Dr. Patel brings over 20-25 years of experience in drug discovery support, drug delivery, and product development, including prior leadership in drug delivery R&D at Pharmacia and Upjohn in Kalamazoo, MI.[[1]](https://biography.omicsonline.org/united-states-of-america/lipocine-inc/mahesh-v-patel-phd-895860)[[3]](https://www.lipocine.com/lipocine-management/)[[5]](https://www.twst.com/interview/Interview-with-the-Chairman-President-and-CEO-Lipocine-Inc-NASDAQ-LPCN/) His expertise spans strategic planning, technology assessment, technical management, and product R&D.[[1]](https://biography.omicsonline.org/united-states-of-america/lipocine-inc/mahesh-v-patel-phd-895860)[[3]](https://www.lipocine.com/lipocine-management/) He holds a B.Pharm from Karnataka University in India, an M.S. in Physical Pharmacy from the University of Cincinnati, and a Ph.D. in Pharmaceutics from the University of Utah.[[1]](https://biography.omicsonline.org/united-states-of-america/lipocine-inc/mahesh-v-patel-phd-895860)[[3]](https://www.lipocine.com/lipocine-management/) As CEO, his total compensation is approximately $761,800 annually, and he owns about 1.96% of Lipocine’s shares, valued at around $1.1 million.[[2]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lpcn/lipocine/management)
查看完整内部人档案 →